Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Oct;68(675):e694-e702.
doi: 10.3399/bjgp18X698885. Epub 2018 Sep 10.

Treatments for subacute cough in primary care: systematic review and meta-analyses of randomised clinical trials

Benjamin Speich  1 , Anja Thomer  2 , Soheila Aghlmandi  1 , Hannah Ewald  3 , Andreas Zeller  2 , Lars G Hemkens  1
Affiliations
Meta-Analysis

Treatments for subacute cough in primary care: systematic review and meta-analyses of randomised clinical trials

Benjamin Speich et al. Br J Gen Pract. 2018 Oct.

Abstract

Background: Subacute cough following a non-specific viral infection lasting 3-8 weeks is common. However, despite many treatment options there are no systematic reviews evaluating these.

Aim: To provide a systematic overview of treatment options and outcomes evaluated in randomised clinical trials (RCTs).

Design and setting: Systematic review and meta-analyses assessing the overall effects of any treatment for subacute cough.

Method: The authors systematically searched PubMed/MEDLINE and the Cochrane Central Register of Controlled Trials (last search March 2017) for RCTs in adult patients with subacute cough. The authors considered trials evaluating any outcome of any drug or non-drug treatments, apart from traditional Chinese and Asian medicines. They combined treatment effects on cough-related outcomes in random effects meta-analyses.

Results: Six eligible RCTs including 724 patients were identified. These assessed montelukast, salbutamol plus ipratropium bromide, gelatine, fluticasone propionate, budesonide, and nociception opioid 1 receptor agonist and codeine. Five studies reported effects on various cough severity scores at various timepoints. No treatment option was associated with a clear benefit on cough recovery or other patient-relevant outcomes in any of the studies or in meta-analyses for cough outcomes at 14 days and 28 days. Reported adverse events were rather mild and reported for 14% of patients across all treatments.

Conclusion: Evidence on treatment options for subacute cough is weak. There is no treatment showing clear patient-relevant benefits in clinical trials.

Keywords: cough; cough score; disease progression; subacute; treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Study selection. RCT = randomised controlled trial.
Figure 2.
Figure 2.
Treatment effects on cough scores after 14 days(A), and 28 days (B). SD = standard deviation. SMD = standard mean difference.
See this image and copyright information in PMC

References

    1. Rosendal M, Carlsen AH, Rask MT, Moth G. Symptoms as the main problem in primary care: a cross-sectional study of frequency and characteristics. Scand J Prim Health. 2015;33(2):91–99. - PMC - PubMed
    1. French CT, Fletcher KE, Irwin RS. A comparison of gender differences in health-related quality of life in acute and chronic coughers. Chest. 2005;127(6):1991–1998. - PubMed
    1. Kuzniar TJ, Morgenthaler TI, Afessa B, Lim KG. Chronic cough from the patient’s perspective. Mayo Clin Proc. 2007;82(1):56–60. - PubMed
    1. Braman SS. Postinfectious cough — ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1):138S–146S. - PubMed
    1. Coenen S, Michiels B, Van Royen P, et al. Antibiotics for coughing in general practice: a questionnaire study to quantify and condense the reasons for prescribing. BMC Fam Pract. 2002;3:16. - PMC - PubMed

LinkOut - more resources